Portfolio company
Dimension Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
IVIVA Medical
This company develops bioartificial implantable kidneys for patients with end-stage renal disease using 3D printing and stem cell technology.
Trestle Biotherapeutics
This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.
CERHUM
This company manufactures 3D-printed bioceramic bone grafts and patient-specific implants for surgeons performing maxillofacial, dental, and orthopaedic reconstructions.
Satellite Bio
This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.
Aspect Biosystems
This company develops bioprinted tissue therapeutics and microfluidic bioprinting technology for pharmaceutical partners and healthcare providers to treat metabolic and endocrine diseases.
